Suppr超能文献

初次及移植角膜中的严重微生物性角膜炎——视力改善的可能性

Severe Microbial Keratitis in Virgin and Transplanted Cornea-Probability of Visual Acuity Improvement.

作者信息

Przybek-Skrzypecka Joanna, Ryk-Adamska Małgorzata, Szewczuk Alina, Skrzypecki Janusz, Izdebska Justyna, Udziela Monika, Rypniewska Anna, Suh Leejee H, Szaflik Jacek P

机构信息

Department of Ophthalmology, Medical University of Warsaw, Sierakowskiego 13, 01-756 Warsaw, Poland.

SPKSO Ophthalmic University Hospital Warsaw, 03-709 Warsaw, Poland.

出版信息

J Clin Med. 2024 Dec 28;14(1):124. doi: 10.3390/jcm14010124.

Abstract

To evaluate visual acuity improvement and identify contributing factors in patients with severe keratitis affecting both virgin and transplanted corneas, treated at a hospital. A retrospective analysis was conducted on 497 patients with unilateral corneal ulcers treated at a tertiary referral center between 2008 and 2023. Data included distance (BCVA) and near best-corrected visual acuity at initial presentation and at discharge, treatments before hospital admission, demographic details, risk factors, clinical signs and symptoms, ancillary test results, and management strategies. Patients were categorized into two groups: Group A (naïve corneal ulcers, 379 patients) and Group B (post-keratoplasty infectious keratitis, 118 patients). Additional analysis focused on patients with presenting visual acuity of at least 1.0 logMAR (≤5/50 Snellen charts = legal blindness) to predict final visual outcomes. The median BCVA at presentation for the entire cohort was 1.9 logMAR, advancing to 1.5 logMAR at discharge ( < 0.001). At least one line improvement in BCVA was observed in 47% of patients (52% of naïve cornea and 33% of transplanted cornea patients). Significantly worse results were observed in Group B were observed for BCVA at presentation, BCVA improvement, and distance and near vision improvement. Among patients with legal blindness at presentation, vision status improved for 52/379 (14%) in Group A and 6/118 (5%) in Group B during hospital admission ( < 0.001), while 67% of the cohort was discharged with VA equal or worse than 5/50. The average hospital stay was 9 days. Near visual acuity got better in 23% of patients (27% in Group A vs. 9% in Group B). A multivariate regression model showed that older age and worse distance BCVA on admission were independent negative predictors of improvement ( < 0.001, < 0.001, respectively) while midperiphery ulcers were associated with better visual outcomes. Hospital admission leads to BCVA improvement in 47% of the patients with severe corneal ulcer, though the prognosis is significantly worse for those with post-keratoplasty microbial keratitis. At discharge, 67% of patients remained at the legal blindness level. Older age and lower BCVA at first presentation are associated with worse prognosis, while ulcers located in the corneal midperiphery are linked to better visual outcomes.

摘要

为评估在一家医院接受治疗的、双眼角膜均受严重角膜炎影响(包括未移植角膜和移植角膜)患者的视力改善情况并确定相关影响因素,对2008年至2023年在一家三级转诊中心接受治疗的497名单侧角膜溃疡患者进行了回顾性分析。数据包括初诊时和出院时的远视力(最佳矫正视力,BCVA)及近视力、入院前的治疗情况、人口统计学细节、危险因素、临床体征和症状、辅助检查结果以及治疗策略。患者被分为两组:A组(单纯角膜溃疡,379例患者)和B组(角膜移植术后感染性角膜炎,118例患者)。进一步分析聚焦于初诊视力至少为1.0 logMAR(≤5/50 Snellen视力表=法定盲)的患者,以预测最终视力结果。整个队列初诊时的BCVA中位数为1.9 logMAR,出院时提高到1.5 logMAR(P<0.001)。47%的患者BCVA至少提高了一行(单纯角膜患者中为52%,移植角膜患者中为33%)。B组在初诊时的BCVA、BCVA改善情况以及远视力和近视力改善方面的结果明显更差。在初诊时为法定盲的患者中,住院期间A组52/379(14%)和B组6/118(5%)的视力状况有所改善(P<0.001),而67%的队列患者出院时视力等于或低于5/50。平均住院时间为9天。23%的患者近视力有所改善(A组为27%,B组为9%)。多因素回归模型显示,年龄较大和入院时远视力BCVA较差是视力改善的独立负性预测因素(分别为P<0.001,P<0.001),而角膜中周边溃疡与更好的视力结果相关。住院治疗使47%的严重角膜溃疡患者BCVA得到改善,不过角膜移植术后微生物性角膜炎患者的预后明显更差。出院时,67%的患者仍处于法定盲水平。年龄较大和初诊时BCVA较低与较差的预后相关,而位于角膜中周边的溃疡与更好的视力结果相关。

相似文献

1
初次及移植角膜中的严重微生物性角膜炎——视力改善的可能性
J Clin Med. 2024 Dec 28;14(1):124. doi: 10.3390/jcm14010124.
2
微生物性角膜炎视力预后的相关因素:一项多中心前瞻性队列研究。
Ophthalmology. 2025 Jul;132(7):830-841. doi: 10.1016/j.ophtha.2025.02.004. Epub 2025 Feb 8.
3
感染性界面性角膜炎(IIK)在板层角膜移植术后:文献回顾。
Ocul Surf. 2019 Oct;17(4):635-643. doi: 10.1016/j.jtos.2019.08.001. Epub 2019 Aug 12.
4
真菌性角膜炎后角膜瘢痕特征与视力的关系。
JAMA Ophthalmol. 2020 Feb 1;138(2):113-118. doi: 10.1001/jamaophthalmol.2019.4852.
5
社会风险因素与微生物性角膜炎患者就诊时视力的相关性。
JAMA Ophthalmol. 2023 Aug 1;141(8):727-734. doi: 10.1001/jamaophthalmol.2023.2415.
6
韩国儿科患者角膜塑形镜相关感染性角膜炎的临床特征和视力预后。
Korean J Ophthalmol. 2024 Oct;38(5):399-412. doi: 10.3341/kjo.2024.0101. Epub 2024 Aug 22.
7
县级医院环境中阿片类药物使用者感染性角膜炎的特征分析
Cornea Open. 2023 Mar;2(1). doi: 10.1097/coa.0000000000000010. Epub 2023 Mar 23.
8
莫拉菌性角膜炎的临床特征与转归
Cornea. 2018 Dec;37(12):1551-1554. doi: 10.1097/ICO.0000000000001749.
9
培养的口腔黏膜上皮移植后的视觉改善。
Ophthalmology. 2013 Jan;120(1):193-200. doi: 10.1016/j.ophtha.2012.07.053. Epub 2012 Oct 16.
10
隐形眼镜相关性青霉角膜炎:危险因素、微生物学特征、临床病程及转归
Semin Ophthalmol. 2017;32(2):157-162. doi: 10.3109/08820538.2015.1011342. Epub 2015 Feb 27.

引用本文的文献

1
1303例患者复发性与原发性角膜炎的比较
J Clin Med. 2025 May 27;14(11):3760. doi: 10.3390/jcm14113760.
2
角膜移植术后微生物性角膜炎的结局:一项16年的分析。
J Clin Med. 2025 May 3;14(9):3165. doi: 10.3390/jcm14093165.

本文引用的文献

1
细菌性角膜炎首选诊疗模式®
Ophthalmology. 2024 Apr;131(4):P87-P133. doi: 10.1016/j.ophtha.2023.12.035. Epub 2024 Feb 13.
2
角膜移植术后感染性角膜炎:一项长期队列研究。
Clin Exp Ophthalmol. 2024 May-Jun;52(4):402-415. doi: 10.1111/ceo.14354. Epub 2024 Jan 24.
3
埃及亚历山大微生物角膜炎的抗生素方案结果和药敏谱发展比较:前瞻性队列研究。
Graefes Arch Clin Exp Ophthalmol. 2024 Jun;262(6):1865-1882. doi: 10.1007/s00417-023-06362-0. Epub 2024 Jan 19.
4
一项关于角膜移植后感染性角膜炎的临床特征、易患因素和结局的 7 年回顾:诺丁汉感染性角膜炎研究。
Front Cell Infect Microbiol. 2023 Aug 30;13:1250599. doi: 10.3389/fcimb.2023.1250599. eCollection 2023.
5
角膜盲与眼库:当前策略与最佳实践。
Indian J Ophthalmol. 2023 Sep;71(9):3142-3148. doi: 10.4103/IJO.IJO_1942_23.
6
感染性角膜炎培养及聚合酶链反应阴性病例的临床特征与转归
Diagnostics (Basel). 2023 Jul 29;13(15):2528. doi: 10.3390/diagnostics13152528.
7
细菌性角膜炎管理的实践模式:一项五大洲调查。
Graefes Arch Clin Exp Ophthalmol. 2023 Jul;261(7):1961-1969. doi: 10.1007/s00417-023-06003-6. Epub 2023 Feb 23.
8
台湾地区住院眼科服务利用情况的全国性人群研究。
BMC Ophthalmol. 2023 Jan 10;23(1):15. doi: 10.1186/s12886-022-02765-5.
9
微生物性角膜炎患者视力预测。
Cornea. 2023 Feb 1;42(2):217-223. doi: 10.1097/ICO.0000000000003129. Epub 2022 Oct 17.
10
印度眼部感染中新兴的抗菌药物耐药性和对抗菌药物管理的需求:叙述性综述。
Indian J Ophthalmol. 2022 May;70(5):1513-1521. doi: 10.4103/ijo.IJO_2537_21.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验